• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯德哥尔摩针头交换项目参与者在新冠疫情期间的健康素养与用药模式变化

Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.

作者信息

Lindqvist K, Wallmofeldt C, Holmén E, Hammarberg A, Kåberg M

机构信息

Stockholm Needle Exchange, Stockholm Centre for Dependency Disorders, Stockholm, Sweden.

Norra Stockholms Psykiatri (Psychiatry of Northern Stockholm), S:t Görans Hospital, Stockholm, Sweden.

出版信息

Harm Reduct J. 2021 May 10;18(1):52. doi: 10.1186/s12954-021-00499-z.

DOI:10.1186/s12954-021-00499-z
PMID:33971892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8107802/
Abstract

BACKGROUND AND AIMS

People who inject drugs may be particularly vulnerable to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to underlying health problems, stigma and social vulnerabilities. Harm reduction services, including needle exchange programs (NEP), have been subjected to varying degrees of disruption in the world, especially in the beginning of the coronavirus disease 2019 (COVID-19) pandemic. Compared to responses in other countries, Sweden's initial strategy toward limiting the spread and impact of COVID-19 was less restrictive to its citizens with no imposed general societal lockdown. In this study, we investigate changes in drug use patterns, utilization of NEP associated health services, COVID-19 health literacy and the prevalence of SARS-CoV-2 antibodies among NEP clients in Stockholm during the COVID-19 pandemic.

METHODS

NEP visits and services provided (needles/syringes, HIV and hepatitis C tests and treatment, naloxone distributed) and overall mortality among NEP clients between January 1 and October 31, 2020, were used for trend analyses in comparison with corresponding 2019 data. Between July 27 and October 2, 2020, NEP clients (n = 232) responded to a 27 item COVID-19 Health Literacy Questionnaire. SARS CoV-2 IgG antibody tests (n = 779) were performed between June 15 and October 31, 2020.

RESULTS

During the COVID-19 pandemic number of clients, client visits, naloxone distribution and HCV tests remained stable compared to 2019, while distribution of needles/syringes increased (p < 0.0001); number of HIV tests and HCV treatments decreased (p < 0.05); and mortality decreased (< 0.01). Overall, the level of health literacy concerning transmission routes and protective measures was high. SARS-CoV-2 antibody prevalence was 5.4% (95% CI 4.0-7.2).

CONCLUSIONS

The Stockholm NEP managed to maintain a high level of clients and services during the pandemic. In general, COVID-19 health literacy was adequate and the overall SARS-CoV-2 antibody prevalence was low compared to the general population, which highlights a need for prioritized and targeted COVID-19 vaccination among PWID.

摘要

背景与目的

由于存在潜在健康问题、耻辱感和社会脆弱性,注射吸毒者可能特别容易感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。包括针头交换项目(NEP)在内的减少伤害服务在全球范围内受到了不同程度的干扰,尤其是在2019冠状病毒病(COVID-19)大流行初期。与其他国家的应对措施相比,瑞典最初限制COVID-19传播和影响的策略对其公民的限制较少,没有实施全面的社会封锁。在本研究中,我们调查了COVID-19大流行期间斯德哥尔摩NEP客户的吸毒模式变化、NEP相关健康服务的利用情况、COVID-19健康素养以及SARS-CoV-2抗体的流行情况。

方法

将2020年1月1日至10月31日期间NEP客户的就诊情况和提供的服务(针头/注射器、艾滋病毒和丙型肝炎检测及治疗、纳洛酮分发)以及总体死亡率与2019年的相应数据进行趋势分析。2020年7月27日至10月2日期间,NEP客户(n = 232)对一份包含27个项目的COVID-19健康素养问卷进行了回答。2020年6月15日至10月31日期间进行了SARS-CoV-2 IgG抗体检测(n = 779)。

结果

与2019年相比,COVID-19大流行期间客户数量、客户就诊次数、纳洛酮分发量和丙型肝炎检测量保持稳定,而针头/注射器的分发量增加(p < 0.0001);艾滋病毒检测次数和丙型肝炎治疗次数减少(p < 0.05);死亡率下降(< 0.01)。总体而言,关于传播途径和保护措施的健康素养水平较高。SARS-CoV-2抗体流行率为5.4%(95%CI 4.0 - 7.2)。

结论

斯德哥尔摩的NEP在大流行期间成功维持了较高的客户数量和服务水平。总体而言,COVID-19健康素养充足,与普通人群相比,SARS-CoV-2抗体总体流行率较低,这突出表明有必要对注射吸毒者优先进行有针对性的COVID-19疫苗接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/432e/8108331/be3f3ebed754/12954_2021_499_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/432e/8108331/233176887a58/12954_2021_499_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/432e/8108331/be3f3ebed754/12954_2021_499_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/432e/8108331/233176887a58/12954_2021_499_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/432e/8108331/be3f3ebed754/12954_2021_499_Fig2_HTML.jpg

相似文献

1
Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.斯德哥尔摩针头交换项目参与者在新冠疫情期间的健康素养与用药模式变化
Harm Reduct J. 2021 May 10;18(1):52. doi: 10.1186/s12954-021-00499-z.
2
Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.英格兰和北爱尔兰注射吸毒人群中 COVID-19 的负担及其对获得卫生和减少伤害服务的影响的初步迹象。
Public Health. 2021 Mar;192:8-11. doi: 10.1016/j.puhe.2021.01.004. Epub 2021 Jan 15.
3
The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.新冠疫情公共卫生措施对澳大利亚监督注射设施就诊和过量用药的影响。
Public Health. 2023 Nov;224:90-97. doi: 10.1016/j.puhe.2023.08.019. Epub 2023 Sep 22.
4
Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.1500 名连续参加斯德哥尔摩针具交换项目的药物滥用者中丙型肝炎的流行率和丙型肝炎检测前知晓率。
Infect Dis (Lond). 2017 Oct;49(10):728-736. doi: 10.1080/23744235.2017.1334263. Epub 2017 Jun 2.
5
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.在 COVID-19 期间调整减少伤害服务:来自澳大利亚监督注射设施的经验教训。
Harm Reduct J. 2021 Feb 17;18(1):20. doi: 10.1186/s12954-021-00471-x.
6
The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.新冠疫情对纽约州毒品使用者健康中心和注射器服务项目的影响:一项定性研究。
Harm Reduct J. 2023 Feb 2;20(1):12. doi: 10.1186/s12954-023-00742-9.
7
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.肯尼亚艾滋病毒感染者和未感染者以及他们的性伴侣中注射毒品者的 SARS-CoV-2 抗体流行率、相关性和获得减少伤害服务的情况。
Harm Reduct J. 2023 Feb 23;20(1):21. doi: 10.1186/s12954-023-00754-5.
8
HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives.哈萨克斯坦在新冠疫情期间为注射吸毒者提供的艾滋病毒护理连续服务:服务提供者观点的定性研究。
Glob Health Sci Pract. 2022 Apr 29;10(2). doi: 10.9745/GHSP-D-21-00619. Print 2022 Apr 28.
9
COVID-19 and Rural Harm Reduction Challenges in the US Southern Mountains.美国南部山区的新冠疫情与减少伤害挑战
J Rural Health. 2021 Jan;37(1):252-255. doi: 10.1111/jrh.12499. Epub 2020 Jul 21.
10
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs.布里斯托新冠肺炎和吸毒人群研究(LUCID-B):一项关于吸毒人群感染新冠经历的定性研究。
Int J Drug Policy. 2021 Dec;98:103391. doi: 10.1016/j.drugpo.2021.103391. Epub 2021 Jul 20.

引用本文的文献

1
Suicidal behavior in patients with severe mental disorders prior to and during the COVID-19 pandemic.2019冠状病毒病大流行之前及期间严重精神障碍患者的自杀行为
Psychol Med. 2024 Dec 16;54(16):1-9. doi: 10.1017/S003329172400299X.
2
Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies.吸毒人群中 SARS-CoV-2 血清流行率和对 COVID-19 mRNA 疫苗的体液免疫反应 - 鉴于量身定制的缓解策略。
Harm Reduct J. 2024 Jun 19;21(1):120. doi: 10.1186/s12954-024-01023-9.
3
Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland.

本文引用的文献

1
Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders.非比寻常的业务——物质使用障碍患者的新冠疫苗接种
N Engl J Med. 2021 Jan 14;384(2):e6. doi: 10.1056/NEJMpv2035709. Epub 2020 Dec 30.
2
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic.美国 COVID-19 疫情期间,急救医疗服务中心观察到的与过量用药相关的心脏骤停事件。
JAMA Psychiatry. 2021 May 1;78(5):562-564. doi: 10.1001/jamapsychiatry.2020.4218.
3
The impact of the COVID-19 pandemic on harm reduction services in Spain.
马里兰州巴尔的摩市注射吸毒者中新冠病毒血清阳性的患病率及其相关因素
Drug Alcohol Depend Rep. 2023 Aug 9;8:100184. doi: 10.1016/j.dadr.2023.100184. eCollection 2023 Sep.
4
The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia.消除丙型肝炎(EC)经验研究:澳大利亚墨尔本注射毒品人群队列的基线特征。
BMJ Open. 2023 Jul 3;13(7):e071665. doi: 10.1136/bmjopen-2023-071665.
5
Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden.在瑞典乌普萨拉的针具交换项目中,注射吸毒者丙型肝炎病毒的流行率、风险因素、治疗接受率和治疗效果。
Harm Reduct J. 2023 Jun 16;20(1):77. doi: 10.1186/s12954-023-00806-w.
6
Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden.在瑞典斯德哥尔摩的一个针具交换项目中,注射吸毒者的真实世界丙型肝炎治疗结果和再感染情况。
Harm Reduct J. 2023 Jun 12;20(1):72. doi: 10.1186/s12954-023-00801-1.
7
Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.瑞典首个带药回家纳洛酮项目:参与者特征、用药剂量终点及逆转过量用药的预测因素。
Subst Abuse Treat Prev Policy. 2023 Apr 22;18(1):24. doi: 10.1186/s13011-023-00533-2.
8
Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis.估算墨西哥提华纳一项警察教育计划对注射吸毒人群中丙型肝炎病毒传播和疾病负担的影响:一项动态建模分析。
Addiction. 2023 Sep;118(9):1763-1774. doi: 10.1111/add.16203. Epub 2023 May 1.
9
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.肯尼亚艾滋病毒感染者和未感染者以及他们的性伴侣中注射毒品者的 SARS-CoV-2 抗体流行率、相关性和获得减少伤害服务的情况。
Harm Reduct J. 2023 Feb 23;20(1):21. doi: 10.1186/s12954-023-00754-5.
10
Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA.远程减少伤害服务是减少类似 COVID-19 危机对吸毒者影响的关键解决方案:来自法国和美国两个独立机构的证据。
Harm Reduct J. 2023 Jan 7;20(1):1. doi: 10.1186/s12954-023-00732-x.
COVID-19 大流行对西班牙减少伤害服务的影响。
Harm Reduct J. 2020 Nov 4;17(1):87. doi: 10.1186/s12954-020-00432-w.
4
Refusals After Prehospital Administration of Naloxone during the COVID-19 Pandemic.在 COVID-19 大流行期间,院前给予纳洛酮后的拒绝。
Prehosp Emerg Care. 2021 Jan-Feb;25(1):46-54. doi: 10.1080/10903127.2020.1834656. Epub 2020 Nov 3.
5
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey.《COVID-19 大流行期间急救医疗服务机构使用纳洛酮情况:全国性调查》。
J Addict Med. 2020 Dec;14(6):e369-e371. doi: 10.1097/ADM.0000000000000746.
6
Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis.新冠疫情对印第安纳波利斯药物滥用的影响。
J Urban Health. 2020 Dec;97(6):802-807. doi: 10.1007/s11524-020-00484-0. Epub 2020 Oct 1.
7
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
8
The first eight months of Sweden's COVID-19 strategy and the key actions and actors that were involved.瑞典 COVID-19 战略的头 8 个月,以及所涉及的关键行动和参与者。
Acta Paediatr. 2020 Dec;109(12):2459-2471. doi: 10.1111/apa.15582. Epub 2020 Oct 11.
9
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.COVID-19 风险和患有物质使用障碍患者的结局:来自美国电子健康记录的分析。
Mol Psychiatry. 2021 Jan;26(1):30-39. doi: 10.1038/s41380-020-00880-7. Epub 2020 Sep 14.
10
Swedish policy analysis for Covid-19.瑞典针对新冠疫情的政策分析。
Health Policy Technol. 2020 Dec;9(4):598-612. doi: 10.1016/j.hlpt.2020.08.009. Epub 2020 Aug 29.